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Pancreatic islet endocrine cell and endothelial cell
(EC) interactions mediated by vascular endothelial
growth factor-A (VEGF-A) signaling are important
for islet differentiation and the formation of highly
vascularized islets. To dissect how VEGF-A signaling
modulates intra-islet vasculature, islet microen-
vironment, and b cell mass, we transiently increased
VEGF-A production by b cells. VEGF-A induction
dramatically increased the number of intra-islet ECs
but led to b cell loss. After withdrawal of the VEGF-A
stimulus, b cell mass, function, and islet structure
normalized as a result of a robust, but transient, burst
in proliferation of pre-existing b cells. Bone marrow-
derived macrophages (MFs) recruited to the site of
b cell injury were crucial for the b cell proliferation,
which was independent of pancreatic location and
circulating factors such as glucose. Identification of
the signals responsible for the proliferation of adult,
terminally differentiated b cells will improve strate-
gies aimed at b cell regeneration and expansion.
INTRODUCTION
Pancreatic islets are highly vascularized and contain a structur-
ally and functionally unique capillary network where each b cell is
in cellular proximity to ECs (Brissova et al., 2006; Nyman et al.,
2008). ECs produce instructive signals necessary for early
pancreatic endoderm specification and endocrine cell differenti-
ation (Lammert et al., 2001; Yoshitomi and Zaret, 2004), but
several recent studies proposed that requirements for blood
vessel-derived signals may differ between early and later stages
of pancreas development (Cai et al., 2012; Magenheim et al.,
2011; Reinert et al., 2014; Sand et al., 2011). VEGF-A produced
by islet endocrine cells is a principal regulator of islet vascular
development and vascular homeostasis (Brissova et al., 2006;498 Cell Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc.Lammert et al., 2003). Inactivation of VEGF-A, either in endocrine
progenitors or differentiated b cells, leads to a profound loss of
intra-islet capillary density, vascular permeability, and islet
function. Though it is clear that altering islet microvasculature
affects insulin delivery into peripheral circulation, the role of
intra-islet ECs and the VEGF-A signaling pathway in regulating
adult b cell mass is not fully understood. Work by Lammert
and colleagues suggests that continuous pancreas-wide over-
expression of VEGF-A from early development to adulthood
results in pancreatic hypervascularization, b cell mass expan-
sion, and islet hyperplasia (Lammert et al., 2001). However, a
more recent report by Agudo et al. reveals that VEGF-A-
stimulated intra-islet EC expansion in adult islets is associated
with reduced b cell mass (Agudo et al., 2012).
b cells of the pancreatic islet have an extremely limited re-
generative potential, so there are major efforts to foster b cell
regeneration in type 1 and type 2 diabetes. Recent studies
have identified several systemic factors and signaling pathways
implicated in b cell replication during increased metabolic de-
mand and following injury (Porat et al., 2011; Rieck andKaestner,
2010), but the role of local islet molecular and cellular factors in b
cell regeneration, and in particular human b cell regeneration, is
unknown.
Increasing evidence suggests that local organ-specific
vascular niches are determinant in organ repair and tumorigen-
esis where ECs produce tissue-specific paracrine growth fac-
tors, defined as angiocrine factors (Butler et al., 2010a). VEGF-A
signaling through its obligatory VEGFR2 receptor plays a critical
role in this process. In addition to this emerging role for the
VEGF-A signaling pathway in organ regeneration via angiocrine
signaling, local increases in VEGF-A production during tissue
injury and tumorigenesis lead to homing of bonemarrow-derived
cells (BMCs), especially monocytes, which express the VEGFR1
receptor (Barleon et al., 1996). While these cells may enhance
VEGF-induced neovascularization, they also actively participate
in tissue repair.
To investigate how VEGF-A signaling modulates intra-islet
vasculature, islet microenvironment, and b cell mass, we tran-
siently increased b cell VEGF-A production in mature mouse
islets (bVEGF-A model). This increased production of VEGF-A
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surprisingly leads to a rapid loss of b cells. Remarkably, 6 weeks
after removing the VEGF-A stimulus, islet morphology, vascular-
ization, mass, and function normalize due to replication of
pre-existing b cells. Using an islet transplantation model with
wild-type (WT) and bVEGF-A islets transplanted under contralat-
eral kidney capsules with or without human islets, we demon-
strate that this b cell replication is independent of the pancreatic
site and circulating factors and is not limited to murine b cells.
Our studies indicate that the local islet microenvironment
modulated by VEGF-A signaling can play an integral role in b
cell regeneration. This process depends on VEGF-A-mediated
recruitment of MFs, which, either directly or cooperatively with
quiescent intra-islet ECs, induce b cell proliferation.
RESULTS
Increased b Cell VEGF-A Production Leads to Islet EC
Expansion and b Cell Loss Followed by b Cell
Regeneration after VEGF-A Normalizes
To dissect the role of the VEGF-A signaling pathway in regulating
adult b cell mass, we used a mouse model of doxycycline
(Dox)-inducible b cell-specific overexpression of human VEGF-
A164 (bVEGF-A) (Efrat et al., 1995; Ohno-Matsui et al., 2002). Islet
VEGF-A production increased rapidly within 24 hr of Dox
treatment (Figure S1A), and robust proliferation of intra-islet
ECs was observed 72 hr after VEGF-A induction (Figure S1B).
We found that a transient increase in b cell VEGF-A production
for 1 week dramatically increased the number of intra-islet ECs
and led to a substantial loss of b cells (Figures 1A and 1B).
One week after Dox withdrawal, VEGF-A expression returned
to baseline (Figure 1C), and remarkably, islet morphology
and vascularization normalized over 6 weeks after removal of
the VEGF-A stimulus (Figures 1D–1F and S1D). The inverse rela-
tionship between b cells and intra-islet ECs during the induction
and withdrawal of the VEGF-A stimulus is shown in Figures 1G
and 1H.
Six weeks after Dox withdrawal, the regenerated bVEGF-A
islets were functionally indistinguishable from No Dox controls
(Figure 1I). bVEGF-Amicemaintained normal glucose clearance,
random blood glucose levels, and body weight during the brief
1 week Dox treatment and subsequent 6 week period of Dox
withdrawal (Figures 1J, 1K, S1E, and S1F). This was expected,
since 1 week Dox treatment resulted in a partial (45%) b cell
loss, as indicated by total pancreatic insulin content (Figure 1L)
and b cell mass measurements (Figure S1G) (Peshavaria et al.,
2006). This b cell loss occurred through upregulation of the
apoptotic pathway (Figure S2) with an increased number of
b cells positive for gamma-phosphorylated histone H2AX
(pH2AX), an apoptotic marker of double-stranded DNA breaks,
1 week after Dox (Figures 1M and S2A) (Lu et al., 2006; Ward
et al., 2008). Pancreatic glucagon was unchanged 1 week after
Dox and during the 6 week period of Dox withdrawal (Fig-
ure S1H). The phenotype of bVEGF-A islets was exacerbated
with prolonged VEGF-A induction (Figures S1I–S1L). Dox treat-
ment for 3 weeks in bVEGF-A mice led to glucose intolerance,
increased fasting glucose levels, and an 80% reduction in total
pancreatic insulin content, with 60% recovery 8 weeks after
Dox withdrawal (Figures S1J–S1L). Prolonged Dox administra-Cetion (3 weeks) alone was not detrimental to glucose homeosta-
sis, islet, or EC morphology (Figures S3C–S3H).
Dox treatment for 1–3 weeks resulted in VEGF-A overexpres-
sion in65% of b cells (Figures 1B and S1M). We did note a very
slight elevation in basal VEGF-A expression in bVEGF-A mice
(Figures 1A and S1A), which caused a modest increase in ECs
adjacent to b cells with elevated VEGF-A expression (2%–5%
b cells). However, glucose clearance in bVEGF-A mice before
Dox administration was identical to both monotransgenic and
WTmice (Figures S1J, S1K, S3G, and S3H and data not shown).
Although islet vasculature became greatly disorganized with
prolonged VEGF-A induction, blood vessels in adjacent exocrine
tissue remained normal (Figure S1N), which is consistent with
the short-range effect of heparin-bound VEGF-A164 observed
in other vascular beds (Carmeliet and Tessier-Lavigne, 2005).
Intravital labeling with endothelium-binding lectin-FITC revealed
that even after 3 weeks of persistent VEGF-A overexpression,
the majority of intra-islet capillaries were still perfused and func-
tional (Figures S1N and S1O) and lined by a thin layer of laminin+
vascular basement membrane (Figures S3A and S3B). We con-
ducted the remainder of our studies on b cell loss and regene-
ration using a 1 week Dox administration and 6 week Dox
withdrawal paradigm to avoid any influence of hyperglycemia.
Withdrawal of the VEGF-A Stimulus Results in Increased
Proliferation of Pre-existing b Cells
To define the time course of b cell regeneration in this model, we
first followed b cell proliferation in the bVEGF-A pancreas during
the course of induction and withdrawal of the VEGF-A stimulus.
One week after Dox treatment, intra-islet ECs were highly prolif-
erative, while b cell proliferation decreased below basal level
(Figures 2A, 2B, and 2G). This Ki67 labeling pattern was reversed
1 week after Dox withdrawal when ECs begin to subside and b
cells proliferate (Figures 2C and 2G). The burst in b cell
proliferation was transient and peaked within 2 weeks after
Dox withdrawal (Figures 2D–2G). The same temporal profile
of b cell replication was seen using BrdU (Figure S3I). Addition-
ally, during 1 week Dox and 6 week recovery phases, the ex-
pression pattern of transcription factor Pdx1, known to be
expressed in progenitor cells of the developing pancreas, did
not differ from No Dox control (Figure S4B), monotransgenic,
or WT mice (data not shown). The number of b cells expressing
the maturation marker MafA decreased after 1 week Dox treat-
ment, but gradually recovered during 6 weeks of Dox withdrawal
(Figures S4C and S4D).
Previous reports indicated that b cell proliferation in the re-
generative phase after STZ-mediated injury is dependent on
re-expression of polycomb group proteins Bmi-1 and Ezh2
that modify chromatin structure at the Ink4a/Arf locus and
control b cell growth (Chen et al., 2009; Dhawan et al., 2009).
To determine if a similar mechanism was responsible for b cell
proliferation in bVEGF-A islets, we labeled pancreatic sections
for Bmi-1 (Figures 2H–2K). Although nearly all b cells were
Bmi-1+ in No Dox controls at postnatal day 21 (Figure 2H), we
did not detect Bmi-1 in b cells of adult bVEGF-A mice 1 or
2 weeks after Dox withdrawal when b cell proliferation reached
a maximum (Figures 2J and 2K). These data suggest that the
mechanism of b cell proliferation in regenerating bVEGF-A islets
differs from the STZ injury model.ll Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc. 499
(legend on next page)
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in this model, we utilized genetic lineage tracing by introducing
Pdx1PB-CreERTm and R26RlacZ components into the bVEGF-A
system. b cells were genetically labeled with a b-galactosidase
(b-gal) reporter using 33 1 mg tamoxifen (Tm) prior to the onset
of Dox treatment. We showed previously that this Tm dose
effectively induces Cre-loxP recombination in 30% of b cells
without undesirable long-lasting residual recombination effects
following Tm administration (Reinert et al., 2012). A similar b
cell recombination rate was achieved when the Pdx1PB-
CreERTm;R26RlacZ lineage tracing system was incorporated
into the bVEGF-A background and was sustained after induction
and withdrawal of the VEGF-A stimulus (Figures 3A–3E). As pre-
viously reported, b-gal+Ins cells were very rare using the
Pdx1PB-CreERTm transgenic line (<1%–3% islet non-b cells)
(Reinert et al., 2012; Zhang et al., 2005). Consistent with the b
cell recombination rate, 30% of Ki67+ b cells carried the
b-gal reporter 2 weeks after Dox withdrawal (Figures 3F and
3G). Maintaining this steady proportion of b-gal+ b cells
throughout the time course indicates that new b cells in
bVEGF-A mice arise by replication from pre-existing b cells
and that the loss of insulin+ cells 1 week after Dox (Figures 1B
and 3B) is the result of b cell death and not the loss of insulin la-
beling or b cell dedifferentiation.
b Cell Replication after VEGF-A Normalization Is
Independent of the Pancreatic Site and Soluble
Circulating Factors and Is Not Limited to Murine b Cells
We next sought to determine whether b cell proliferation in
regenerating bVEGF-A islets required the pancreatic location
and/or was dependent on soluble circulating factor(s). We also
wanted to know whether the factor(s) responsible for this murine
b cell proliferation were capable of inducing proliferation in
human b cells. To address these questions, we used an islet
transplantation model where handpicked WT and bVEGF-A
islets were transplanted beneath contralateral kidney capsules
of bVEGF-A mice, or alternatively, mixtures with equal amounts
of human and WT or bVEGF-A islets were transplanted beneath
contralateral kidney capsules of immunodeficient NOD-scid-
IL2rgnull mice (Figure 4A). All human islets (HI) used in these ex-
periments demonstrated a robust insulin secretory response to
glucose, and this response was further augmented by cAMP
potentiation (Figure S5H) (Dai et al., 2012). Transplanted islets
were allowed to engraft for 2 weeks, and then the tissues were
analyzed at baseline without Dox, 1 week after Dox treatment,Figure 1. Increasing b Cell VEGF-A Production Increases Intra-Islet E
Withdrawal of the VEGF-A Stimulus
(A–M) VEGF-A was induced for 1 week (wk) by Dox administration followed by 6 w
and EC marker CD31 (green). Scale bar is 50 mm and applies to (A)–(F). (G and H
withdrawal of the VEGF-A stimulus. ***p < 0.001, 1 week Dox, 1 weekWD, 2 week
control; n = 4 mice/time point. Islet size measured by pixel area increased slightly
1 week Dox, 10705 ± 1712 pixels, p = 0.1939. (I) Islets isolated from No Dox con
system. Both groups had normal basal insulin secretion at 5.6 mM glucose (G
stimulated with either 16.7mMglucose (G 16.7; 9.6 ± 2.1 versus 11.3 ± 2.5 ng/100
versus 84 ± 13 ng/100 IEQ, p = 0.34). Inset shows enlarged boxed portion of insu
1 week Dox (n = 10) versus No Dox (n = 14) or 6 week WD (n = 5). (L) Loss in pa
6weeks following Doxwithdrawal. **p < 0.01, 1week Dox versus NoDox; *p < 0.05
versus 6 week WD was not statistically significant; n = 6–7 mice/time point. (M) In
100–500 b cells analyzed/mouse. ***p < 0.001, 1 week Dox versus No Dox. Data
Ceand 2 weeks after Dox withdrawal (Figure 4A). After 1 week of
Dox treatment, VEGF-A was induced as effectively in bVEGF-A
islet grafts (Figure S5E) as in native bVEGF-A islets (Figure 1B),
with both sites showing an extensive increase in EC mass and
b cell loss (Figures S5E and S5J). We noted that 1 week after
VEGF-A induction, ECswere assembled intomultiple layers (Fig-
ures 1B, S5E, and S5J). This was followed by a gradual rear-
rangement in endothelial and islet cells as ECs transitioned to
amore single-layered organization 2 weeks after Doxwithdrawal
(Figures 1D, S5G, and S5L). Similar changes in graft morphology
were observed in bVEGF-A grafts both with and without human
islets (Figures S5E, S5G, S5J, and S5L). Increased VEGF-A
production in bVEGF-A islet grafts and native bVEGF-A islets
had no effect on the vascularization of WT islet grafts in contra-
lateral kidneys (Figures S5D, S5F, S5I, and S5K) or the kidney
cortex adjacent to bVEGF-A islet grafts (data not shown), point-
ing again to the localized effect of VEGF-A164.
We next measured b cell proliferation rates in WT and
bVEGF-A islet grafts at No Dox, 1 week after Dox treatment,
and 2 weeks after Dox withdrawal (Figures 4B–4D) when b cell
proliferation was maximal in native bVEGF-A islets (Figure 2G).
As expected, the b cell proliferation rate was similar in WT and
bVEGF-A islet grafts at No Dox and 1 week after Dox treatment
(Figure 4D). This low proliferation rate continued inWT islet grafts
2 weeks after Dox withdrawal (1.3 ± 0.2%), but the b cell replica-
tion index in bVEGF-A islet grafts increased 4-fold (4.2 ± 0.8%)
and was comparable to that in native bVEGF-A islets (6.2 ±
0.7%). Similarly, 2 weeks after Dox withdrawal, the proliferation
rate of human b cells in bVEGF-A + HI grafts was 3-fold higher
(0.95 ± 0.18%) than in WT+HI grafts (0.35 ± 0.07%) (Figures
4E–4G). Collectively, these data indicate that b cell replication
in regenerating bVEGF-A islets is modulated by the local micro-
environment independently of the pancreatic site and systemic
soluble factors. Furthermore, the factor(s) responsible for b cell
proliferation in bVEGF-A islets also promote significant prolifera-
tion of human b cells.
Recruited MFs Are Crucial for the b Cell Proliferative
Response in bVEGF-A Islets
Since VEGF-A is known to stimulate the migration of circulating
monocytes (Barleon et al., 1996), and b cell proliferation was
modulated by the local microenvironment created by increased
VEGF-A expression, we sought to determine whether circulating
monocytes homed to bVEGF-A islets upon VEGF-A induction
and contributed to the b cell proliferative response.Cs but Leads to b Cell Loss Followed by b Cell Regeneration after
eeks of Dox withdrawal (WD). (A–F) Labeling for insulin (Ins, blue), VEGF-A (red),
) Relationship between b cells (G) and intra-islet ECs (H) upon induction and
WD, or 3 weekWD versus No Dox control; *p < 0.05, 6 weekWD versus No Dox
but not significantly with intra-islet EC expansion; No Dox, 6545 ± 1687 pixels;
trols and at 6 week WD (n = 4 mice/group) were examined in a cell perifusion
5.6), and the magnitude of the insulin secretory response was similar when
IEQ, p = 0.63) or 16.7mMglucose + 100 mM IBMX (G 16.7 + IBMX 100; 111 ± 22
lin secretory profile. (J and K) Glucose clearance in bVEGF-A mice. **p < 0.01,
ncreatic insulin content 1 week after VEGF-A induction was restored over the
, 2 weekWD versus NoDox; #, p < 0.05, 1week Dox versus 6weekWD; NoDox
creased b cell apoptosis 1 week after VEGF-A induction; n = 4 mice/time point;
are shown as the means ± SEM.
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Figure 2. Removal of the VEGF-A Stimulus Results in a Transient Burst in b Cell Proliferation
(A–K) b cell proliferation was monitored during the experimental period outlined; n = 4 mice/time point. (A–F) Labeling for insulin (Ins, blue), Ki67 (red), and CD31
(green). Scale bar is 50 mm and applies to (A)–(F). (G) Quantification of b cell proliferation. ##, p < 0.01, 1 week Dox versus No Dox, 1 week WD, 2 week WD, or
3 week WD. **p < 0.01, 1 week WD or 2 week WD versus No Dox, 1 week Dox, 3 week WD, or 6 week WD. No Dox, 1 week Dox, 3 week WD, and 6 week WD
comparisons were not statistically significant. (H–K) Increased b cell proliferation was not associated with increased Bmi-1; insulin (Ins, green), Bmi-1 (red), Dapi
(blue). Scale bar is 25 mm and applies to (H)–(K). Data are shown as the means ± SEM.
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Figure 3. New b Cells in the bVEGF-A Model Arise from Replication of Pre-existing b Cells
(A–G) b cells in RIP-rtTA;Tet-O-VEGF-A;Pdx1PB-CreERTm;R26Rwt/lacZ transgenic mice were genetically labeled by Tm injection 2 weeks prior to inducing VEGF-A
for 1 week by Dox administration followed by 6 weeks of Dox withdrawal. Expression of b-gal in b cells was analyzed in 3–4 mice/time point. (A–D) Labeling for
insulin (Ins, blue), b-galactosidase (b-Gal, red), and CD31 (green). Scale bar is 50 mm and applies to (A)–(D). (E) b-gal labeling index in b cells was not statistically
different at any time point, p = 0.2760. (F) Genetically labeled b cells proliferate. Arrowheads denote b-gal+Ki67+ b cells, progeny of surviving and proliferating b
cells (enlargement in inset). Arrows point to b-galKi67+ b cells. Scale bar is 50 mm. (G) One-third of all proliferating b cells expressed the b-gal genetic mark,
which is consistent with genetic labeling in (E). The b cell proliferation index at 2 week WD was 6.1% ± 1.0%, consistent with Figure 2G. Data are shown as the
means ± SEM.
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marrow. After bone marrow reconstitution, VEGF-A induction
stimulated amarked infiltration of BMCs to the site of b cell injury,
and they persisted in islet remnants during the b cell regeneration
phase (2 weeks after Dox withdrawal) (Figures 5A–5C). Although
GFP+ recruited BMCs were adjacent to b cells and ECs, we did
not detect any GFP+/Ins+ cells or GFP+/CD31+ cells. Occa-
sional GFP+ cells were noted around bVEGF-A islets at
No Dox (Figures 5A and 5D), but 1 week of VEGF-A induction
increased their infiltration nearly 6-fold (Figure S6A). This high
level of BMC infiltration into bVEGF-A islets was sustained
even 2 weeks after withdrawing the VEGF-A stimulus (Fig-
ure S6A), the time point when b cell proliferation is at amaximum.
Nearly all GFP+ recruited BMCs expressed the pan-hema-
topoietic marker CD45 (Figures 5D–5F), and BMC infiltration
monitored by CD45 labeling was consistent in mice with or
without bone marrow transplantation (data not shown), indi-
cating that the bone marrow transplantation alone did notCeenhance the incidence of recruited BMCs in the pancreas and
islets. This allowed us to use CD45 as a surrogate marker to
follow the BMC infiltration.
Flow cytometry analysis of cells from bVEGF-A islets
dispersed after 1 week VEGF-A induction revealed that the
vast majority (90%) of CD45+ recruited BMCs were CD11b+
Gr1 MFs (Figure 6A). As monocytes develop into mature
MFs, they lose Gr1 expression and increase expression of
mature MF markers CD11b and F4/80 (Sharpe et al., 2006).
This maturation process is evident in the CD45+ BMCpopulation
recruited to bVEGF-A islets where only a few less-mature MFs
(CD11b+LO) express F4/80 (3%), while more-mature MFs
(CD11b+HI) are much more likely to express F4/80 (60%)
(Figure 6B). Labeling tissue sections from mice that received
GFP bone marrow transplants with F4/80 confirmed that nearly
all GFP+ recruited BMCs in bVEGF-A islets were MFs (Figures
S6B–S6D). GFP+ cells expressing the T cell marker CD3 or
the B cell marker B220 were very rare (Figures S6E–S6J), andll Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc. 503
Figure 4. bCell Replication Is Independent of
the Pancreatic Site and Soluble Circulating
Factors and Is Not Limited to Murine b Cells
(A) Islets from bVEGF-A mice and WT controls were
transplanted into bVEGF-A recipients or mixed with
human islets (HI) and transplanted into NOD-scid-
IL2rgnull mice. Islets engrafted for 2 weeks then
grafts were harvested and analyzed at No Dox,
1 week Dox, and 2 week WD time points; n = 3–4
mice/time point.
(B and C) b cell proliferation at 2 weekWD inWT and
bVEGF-A islet grafts; insulin (Ins, green), Ki67 (red),
and Dapi (blue). Scale bar is 50 mmand applies to (B)
and (C).
(D) Quantification of b cell proliferation in WT and
bVEGF-A islet grafts. **p < 0.01, 2 week WD versus
No Dox and 1 week Dox across graft types.
(E and F) b cell proliferation at 2 week WD in WT+HI
and bVEGF-A+HI grafts; human C-peptide
(hC-peptide, green), Ki67 (red), and Dapi (blue).
Scale bar is 50 mm and applies to (E) and (F).
(G) Quantification of b cell proliferation inWT+HI and
bVEGF-A+HI grafts at 2 week WD. *p < 0.05. Data
are shown as the means ± SEM.
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induction does not lead to neutrophil accumulation (Figures
S6K and S6L).
Together, these data indicate that upon VEGF-A induction,
circulating monocytes migrate to bVEGF-A islets and differen-
tiate into a mature population of recruited MFs that remain in
the islets 2 weeks after the VEGF-A stimulus is withdrawn. In
contrast, CD45+ cells were extremely rare in islet remnants after
STZ-mediated b cell ablation, and b cell recovery was limited, as
indicated by persistent hyperglycemia 6 weeks after STZ treat-
ment (data not shown).
The pattern of CD45 labeling in bVEGF-A islet grafts was
similar to native bVEGF-A islets. VEGF-A induction led to the
infiltration of CD45+ cells into bVEGF-A islet grafts, and they504 Cell Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc.persisted within the grafts 2 weeks after
VEGF-A stimulus withdrawal, while the
population of CD3+ and B220+ cells
remained extremely low (data not shown).
The incidence of CD45+ cells within WT
islet grafts remained low at all three time
points with the rare presence of T and B
cells (data not shown). Some CD45+ cells
were detected around the periphery of
islet grafts regardless of the islet genotype
and VEGF-A induction, which could be
due to the islet transplantation procedure
and engraftment process being incom-
pletely resolved. Also, VEGF-A production
is increased in isolated islets as a result
of hypoxia (Vasir et al., 2001), which alone
could stimulate some recruitment of
CD45+ cells even in WT islet grafts. Im-
portantly, the infiltration of CD45+ cells
was consistently observed only in
bVEGF-A islets and bVEGF-A islet graftsafter VEGF-A induction (Figure 5, and data not shown). Similar
to native bVEGF-A islets, the majority of CD45+ cells in
bVEGF-A grafts were F4/80+ MFs (data not shown). In
contrast, F4/80+ cells were rare within WT islet grafts (data not
shown).
To determine whether these recruited MFs contribute to
the b cell proliferative response during regeneration, we
blocked recruitment of MFs to bVEGF-A islets by partial bone
marrow ablation (5 Gy irradiation). This methodology has been
widely used for MF inactivation (Diamond and Pesek-Diamond,
1991; Ricardo et al., 2008; Wang et al., 2011), and prior
studies have shown that 5 Gy irradiation alone neither inhibits
nor promotes b cell proliferation (Nakayama et al., 2009; Urba´n
et al., 2008). Immediately after receiving 5 Gy irradiation,
Figure 5. CD45+ BMCs Are Recruited to the Site of b Cell Injury upon VEGF-A Induction and Persist in Islet Remnants during b Cell Regen-
eration
(A–F) bVEGF-Amice were transplanted with GFP+ bonemarrow, and 8weeks later VEGF-Awas induced for 1 week by Dox administration followed by 2weeks of
Dox withdrawal; n = 4–6mice/time point. (A–C) Labeling for insulin (Ins, blue), CD31 (red) and GFP (green). (D–F) Labeling for insulin (Ins, blue), pan-hematopoietic
marker CD45 (red) and GFP (green). Boxes in (A)–(F) denote enlargements in (A0)–(F0). Scale bar in (A) is 50 mm and applies to (A)–(F). Scale bar in (A0) is 50 mm and
applies to (A0)–(F0).
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Figure 6. Recruitment of MFs into bVEGF-A Islets upon VEGF-A Induction Is Necessary for the b Cell Proliferative Response
(A and B) Flow cytometry analysis of bVEGF-A islets after 1 week Dox treatment. (A) The CD45+ BMC population recruited to bVEGF-A islets was composed of
90% CD11b+ MFs and 3% Gr1+ cells. (B) F4/80 expression in subsets of more mature CD11b+HI (60%) and less mature CD11b+LO (3%) MFs; n = 5 islet
preparations (1–2 mice/preparation).
(C–G) Partial bone marrow ablation prior to VEGF-A induction blocks MF recruitment and prevents b cell proliferation. (C and D) Immediately after sublethal
irradiation, VEGF-A expression in bVEGF-A mice was induced for 1 week by Dox administration, and tissues were examined for the presence of CD45+ MFs at
1 week Dox and compared with nonirradiated controls; n = 4 mice/group; insulin (Ins, blue), CD45 (red), and EC marker caveolin-1 (Cav-1, green). (C0) and (D0)
show CD45 (red) and caveolin-1 (green) labeling. Scale bar is 50 mm and applies to (C)–(D0 ). (E) Sublethal irradiation reduced infiltration of CD45+ MFs, ***p <
0.001, 0 Gy versus 5 Gy. (F) Sublethal irradiation did not affect intra-islet EC expansion, p = 0.5760, 0 Gy versus 5 Gy. (G) Two weeks after Dox withdrawal, b cell
proliferation was significantly reduced in sublethally irradiated bVEGF-A mice versus nonirradiated controls, **p < 0.01; n = 4 mice/group. Data are shown as the
means ± SEM.
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Figure 7. Transcriptome Analysis of
bVEGF-A Islets and Purified Islet-Derived
MFs and ECs
(A–C) Gene expression profile of whole bVEGF-A
islets, islet-derived MFs, and islet-derived ECs by
RNA-Seq; n = 3 replicates/each sample set. (A)
Differential expression of b cell-, EC-, and MF-
specific genes, phagocytosis-related genes, MF
phenotype markers (M1, classical; M2, alternative),
chemokines, cytokines, cell adhesion molecules,
growth factors, and matrix degrading enzymes be-
tween islets at 1 week Dox versus No Dox, p < 0.05
for fold changeR 2. See also data in Figure S6M. (B)
At 1 week Dox, recruited MFs are highly enriched
for transcripts of phagocytosis-related genes, M2
markers, chemokines, cytokines, cell adhesion
molecules, and metalloproteinases involved in tis-
sue repair. (C) Intra-islet ECs mainly express growth
factors andmatrix degrading enzymes that facilitate
growth factor release from the extracellular matrix.
Data in (B) and (C) are plotted as mean ± SEM.
(D) Paradigm for the role of MF-EC interactions in
b cell regeneration. Upon VEGF-A induction, intra-
islet ECs proliferate and circulating monocytes
recruited to islets differentiate into MFs. These
CD45+CD11b+Gr1 recruited MFs and ECs
produce effector molecules that either directly or
cooperatively induce b cell proliferation and regen-
eration. Data are shown as the means ± SEM.
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bone marrow ablation significantly reduced infiltration of
CD45+ MFs to bVEGF-A-overexpressing islets (Figures 6C–
6E). In spite of the greatly reduced MF population, intra-islet
ECs continued to expand, resulting in b cell loss (Figure 6F).
However, subsequent measurement of the Ki67 labeling
index in b cells 2 weeks after Dox withdrawal showed reduced
MF infiltration into bVEGF-A islets resulting in an 3-fold
decrease in b cell proliferation (Figure 6G). These results suggest
that recruited MFs support b cell proliferation following islet
injury.Cell Metabolism 19, 498–Both MFs and ECs in the bVEGF-A
Islet Microenvironment Produce
Factors that Promote Tissue Repair/
Regeneration
Tissue regeneration is a multistep process
that is mediated by complex interactions
between multiple cell types (Nucera et al.,
2011). Because recruited MFs and intra-
islet ECs are two major components of
the bVEGF-A islet microenvironment at
the onset of b cell regeneration, we postu-
lated that MFs produce effector molecules
that induce b cell proliferation/regenera-
tion either directly or in concert with intra-
islet ECs. To identify the components and
cellular sources of intra-islet signaling at
the onset of b cell proliferation, we per-
formed transcriptome analysis of whole
bVEGF-A islets isolated at No Dox and
1 week after VEGF-A induction, whenboth ECs and MFs are most abundant in islets, and compared
their transcriptional profiles to purified islet-derived MFs and
ECs (Figures 7A–7C and S7). Our data revealed that some
factors are unique to individual cell types and some are shared
by MFs and ECs. For example, after 1 week VEGF-A induction,
recruited MFs were highly enriched for transcripts of phagocy-
tosis-related genes (Axl, Fcrls, Cd14), markers of alternatively
activated MFs (M2) (Cd36,Mrc1,Msr1), somemarkers of classi-
cally activated MFs (M1) (Ccr7, Cd80, Fcgr3), chemokines
(Ccl12, Ccl2, Cxcl10, Cxcl2), cytokines (Il10, Il10ra, Il4ra, Tnf),
cell adhesion molecules (Icam1, Vcam1), metalloproteinases511, March 4, 2014 ª2014 Elsevier Inc. 507
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growth factors (Hgf, Igf1, Pdgfb, Tgfb1, Tgfbi) (Figure 7B). In
contrast, intra-islet ECs mainly expressed growth factors (Ctgf,
Fgf1, Igf1, Pdgfb) and matrix-degrading enzymes (Adam12,
Adamts9) that facilitate growth factor release from the extra-
cellular matrix (Figure 7C) (Apte, 2009; Kveiborg et al., 2008).
Additionally, our data indicate that intra-islet ECs produce fac-
tors (Tgfb family; including Tgfb1, Tgfb2) and cell adhesion
molecules (Icam2, Mcam) directly involved in monocyte recruit-
ment and M2 MF activation (Bardin et al., 2009; Ricardo et al.,
2008; Tsunawaki et al., 1988). These data provide strong evi-
dence for a model of b cell regeneration where factors produced
by both recruited MFs and intra-islet ECs create amicroenviron-
ment that promotes b cell proliferation (Figure 7D).
DISCUSSION
VEGF-A is a master regulator of islet vascular patterning,
microvascular permeability, and function, but the role of the
VEGF-A signaling pathway and intra-islet ECs in regulating b
cell mass is incompletely understood. Here we used a model
of inducible and reversible b cell-specific VEGF-A overexpres-
sion to investigate how VEGF-A signaling modulates intra-islet
vasculature, islet microenvironment, and b cell mass. Increasing
intra-islet ECs by transient VEGF-A induction surprisingly led to
reduced, not increased, b cell mass. However, withdrawal of
the VEGF-A stimulus created a local microenvironment that
promoted robust b cell proliferation, with restoration of b cell
mass, islet architecture, and vascularization. This proliferation,
which was independent of the pancreatic environment or sys-
temic factors, required recruitment of MFs to the site of islet
regeneration. Based on these findings, we propose a mecha-
nism to induce b cell regeneration involving recruited MFs and
intra-islet ECs (discussed below).
Transiently increased VEGF-A production in adult b cells in our
model resembled recently described restrictive effects of
hypervascularization on pancreatic epithelial branching, endo-
crine cell differentiation, and b cell mass (Agudo et al., 2012;
Cai et al., 2012; Magenheim et al., 2011; Sand et al., 2011) and
contrasted with previously reported islet hyperplasia in a Pdx1-
VEGF-A transgenic model (Lammert et al., 2001). Similar delete-
rious effects of VEGF-A-induced neovascularization were
observed previously in liver and heart (Grunewald et al., 2006).
In our study, a significant decrease in b cell proliferation and
mass and increased apoptosis were observed when intra-islet
ECs became proliferative. It is possible that activated ECs
produce factors causing b cell loss, or b cells regress due to
space constraints and perturbed cell-cell contacts within the
islet caused by rapid EC outgrowth. Although the expanding islet
endothelium became disorganized, it is unlikely that the loss of b
cells was caused by lack of blood flow or hemorrhage, since islet
vasculature was perfused as shown by labeling with endothe-
lium-binding lectin (Brissova et al., 2006). Determining the exact
cause(s) of b cell death will require additional investigation.
Taken together, we show that precise control of VEGF-A produc-
tion in adult b cells is crucial for islet vascular homeostasis and
maintenance of normal b cell mass. This is important for efforts
to utilize ECs in embryonic stem cell differentiation protocols or
to promote islet survival after islet transplantation.508 Cell Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc.Withdrawal of the VEGF-A stimulus in bVEGF-A islets led to a
remarkably rapid recovery of b cells by a transient increase in
proliferation. Lineage tracing analysis showed that b cell prolifer-
ation from pre-existing b cells was the main mechanism of b cell
recovery in the bVEGF-A model. Furthermore, using a transplan-
tation model with WT and bVEGF-A islets transplanted under
contralateral kidney capsules, we were able to exclude systemic
effects of soluble factors, namely glucose (Porat et al., 2011),
and demonstrate conclusively that b cell proliferation following
injury was stimulated by signals derived from the local islet
milieu. Remarkably, these localized signals were also able to
significantly increase human b cell proliferation.
Although b cell proliferation in the bVEGF-A model is indepen-
dent of systemic soluble factors, we found that islet vascular
expansion and b cell loss were accompanied by a dramatic
infiltration of CD45+CD11b+Gr1 MFs. In addition, our data
demonstrate that recruited MFs infiltrating bVEGF-A islets and
islet grafts neither incorporate into islet vasculature nor differen-
tiate into insulin-producing cells, but instead remain in close
association with b cells and intra-islet ECs. This robust recruit-
ment of MFs is, for example, very distinct from the STZ-medi-
ated model of b cell injury where transplantation of BMCs has
an extremely limited effect on b cell recovery and BMCs were
mostly found around pancreatic ducts (Hasegawa et al., 2007;
Hess et al., 2003). Moreover, when the recruitment of CD45+
CD11b+Gr1 MFs in our model was blocked by partial bone
marrow ablation, b cell proliferation was greatly reduced, sug-
gesting that infiltration of these MFs is crucial for the b cell
proliferative response in regenerating bVEGF-A islets. Depend-
ing on the microenvironment, MFs can acquire distinct func-
tional phenotypes. Two well-established MF phenotypes are
often referred to as classically activated proinflammatory MFs
(M1) and alternatively activated MFs (M2) that promote tissue
repair/regeneration through phagocytosis, scar tissue digestion,
and growth factor secretion and release from the extracellular
matrix (Sica and Mantovani, 2012). Transcriptome analysis
showed thatMFs recruited to bVEGF-A islets express high levels
of M2 markers along with MMPs associated with tissue restora-
tion and remodeling, and lower levels of M1 markers, indicating
that these MFs likely have a unique regenerative phenotype
(Ricardo et al., 2008; Sica and Mantovani, 2012). Very little is
known about the role of MFs in adult b cell maintenance, but
during late stages of pancreatic development, mice with severe
MF deficiency had reduced b cell proliferation, b cell mass, and
impaired islet morphogenesis (Banaei-Bouchareb et al., 2004).
While recruited MFs are present in bVEGF-A islets during
VEGF-A induction, b cell proliferation does not begin until
1 week after Dox withdrawal, when intra-islet ECs switch from
proliferative angiogenesis to quiescence, suggesting that quies-
cent intra-islet ECs provide permissive or instructive signals for
the b cell regenerative process. These islet-derived ECs produce
several modulators of cell proliferation and also secreted factors
that direct M2 MF activation (He et al., 2012; Tsunawaki et al.,
1988). Recent work from several groups suggests that organ-
specific vascular niches and VEGF-A-VEGFR2 signaling are
major determinants in organ repair and tumorigenesis where
ECs produce tissue-specific paracrine growth factors, termed
angiocrine factors (Butler et al., 2010a). For example, during liver
regeneration, sinusoidal ECs provide the vascular niche required
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such as HGF and Wnt2 (Ding et al., 2010). In bone marrow,
stress-induced expression of Notch ligands by sinusoidal ECs
is necessary for hematopoietic stem cell reconstitution (Butler
et al., 2010b). After a partial lung ablation, pulmonary capillary
ECs stimulate proliferation of epithelial progenitor cells through
processes involving VEGFR2 and FGFR1 activation and produc-
tion of MMP14 (Ding et al., 2011). Furthermore, production of
angiocrine factors by tumor vessels directly leads to tumor
progression (Butler et al., 2010a). In the pancreas, VEGF-A-
VEGFR2 signaling is a principal regulator of islet capillary
network formation and maintenance (Brissova et al., 2006; Lam-
mert et al., 2003). In addition, ECs are critical for induction of islet
endocrine cell differentiation (Lammert et al., 2001; Yoshitomi
and Zaret, 2004), and early loss of ECs in developing islets leads
not only to reduced b cell mass at birth but also reduced basal b
cell proliferation in the adult (Reinert et al., 2013). Transcriptional
profiling of intra-islet ECs suggests that they contribute to b cell
regeneration by facilitating monocyte recruitment and M2 MF
activation and by producing an array of growth factors and
MMPs that increase growth factor bioavailability.
The main challenge of b cell replacement therapy is deter-
mining how to generate a sufficient quantity of high-quality
mature human b cells. Therefore, understanding mechanisms
that modulate b cell regeneration and fostering this process
may help rescue remaining b cell mass in type 1 and type 2
diabetes. Based on our findings, we propose a model of b cell
regeneration (Figure 7D) where the local islet microenvironment,
dynamically modulated by VEGF-A, plays an integral part in the b
cell regenerative process. Increased VEGF-A production in adult
b cells results in intra-islet EC activation and b cell loss, which
demonstrates the essential role of regulated VEGF-A signaling
in maintaining islet vascular homeostasis and b cell mass. At
the same time, however, islet VEGF-A induction leads to the
recruitment of CD45+CD11b+Gr1 MFs. After withdrawal of
the VEGF-A stimulus, these recruited M2-like MFs persist in islet
remnants and produce effector molecules that directly, or in
concert with quiescent intra-islet ECs, promote b cell prolifera-
tion and regeneration independent of the pancreatic site and
systemic factors.
It will be important to further characterize the MFs responsible
for the b cell proliferative effect and determine how to promote
their recruitment to pancreatic islets. Furthermore, under-
standing signals derived from the intra-islet endothelium will
allow us to define the mechanism by which these recruited
MFs promote b cell proliferation and develop them as a potential
therapeutic for diabetes.EXPERIMENTAL PROCEDURES
Mouse Models
Bitransgenic mice with Dox-inducible b cell-specific overexpression of human
VEGF-A164 were generated by crossing RIP-rtTA male mice and Tet-O-
VEGF-A female mice, both on a C57BL/6 background (Efrat et al., 1995;
Ohno-Matsui et al., 2002). Mice for lineage tracing analysis were generated
by crosses of the Pdx1PB-CreERTm line (Zhang et al., 2005) and R26RlacZ/lacZ
reporter strain (Soriano, 1999) with RIP-rtTA and Tet-O-VEGF-A transgenic
mice. VEGF-A transgene expression was activated in 10- to 12-week-old
mice by Dox administration (5mg/ml) in light-protected drinking water contain-
ing 1% Splenda for a period of 1–3 weeks. For lineage tracing analysis, b cellsCewere genetically marked with b-gal by s.c. Tm injection 2 weeks prior to Dox
administration (Reinert et al., 2012). C57BL/6 mice and GFPC57BL/
6-Tg(CAG-EGFP)1Osb/J mice were obtained from The Jackson Laboratory
(Bar Harbor, ME). Human islets were transplanted into immunodeficient
NOD-scid-IL2rgnull mice (King et al., 2008). Genotyping was performed on
tail biopsies with primers previously described (Efrat et al., 1995; Ohno-Matsui
et al., 2002; Soriano, 1999; Zhang et al., 2005). All animal studies were
approved by the Institutional Animal Care and Use Committee at Vanderbilt
University Medical Center.
Islet Isolation and Transplantation
Islets were isolated by intraductal infusion of collagenase P as described
(Brissova et al., 2004). WT C57BL/6 and bVEGF-A islets were transplanted
under contralateral kidney capsules into bVEGF-A recipients as described
(Brissova et al., 2004). Human islets from three donors with an average age
of 23 years (range 20–28) and average BMI of 28.7 (range 19.0–33.8) were
obtained through the Integrated Islet Distribution Program.Mixtures with equal
amounts of human and WT or bVEGF-A islets (100 islet equivalents/per each
group) were transplanted beneath contralateral kidney capsules of immunode-
ficient NOD-scid-IL2rgnull mice.
Bone Marrow Isolation and Transplantation
Bone marrow was harvested from cleaned femurs and tibias of 6-week-old
GFPC57BL/6-Tg(CAG-EGFP)1Osb/J donors (Okabe et al., 1997) by flushing
them with RPMI-1640 medium containing 2% fetal bovine serum plus heparin
(5 U/ml). Six-week-old bVEGF-A recipients received a single dose of lethal
irradiation (9 Gy) followed by injection of 5 3 106 bone marrow cells delivered
in 200 ml of RPMI-1640 media via the retro-orbital sinus. Recipients were
treated with 100 mg/l neomycin and 10 mg/l polymyxin B sulfate (X-Gen
Pharm) in drinking water beginning 3 days prior to irradiation and continuing
for 3 weeks after bone marrow transplantation. Hematopoietic engraftment
was assayed 8 weeks after transplantation as well as after 1 week Dox, and
2 weeks after Dox withdrawal by flow cytometry analysis. All animals achieved
high hematopoietic chimerism (>80%). Partial bone marrow ablation was
achieved with 5 Gy irradiation (Wang et al., 2011).
Flow Cytometry
Details of the procedures are available in the Supplemental Experimental
Procedures.
Tissue Collection and Immunocytochemistry
Collection of pancreata or kidneys bearing islet transplants and immunocyto-
chemistry were performed as described (Brissova et al., 2006). Details of the
procedures are available in the Supplemental Experimental Procedures.
Glucose Tolerance Testing, Islet Function, and Pancreatic Hormone
Content
Methodologies for glucose tolerance testing, islet function, and pancreatic
hormone content were previously described (Brissova et al., 2006).
Details of the procedures are available in the Supplemental Experimental
Procedures.
RNA Sequencing and Analysis
Details of the procedures are available in the Supplemental Experimental
Procedures.
Statistical Analysis
Unpaired t test and one-way analysis of variance with Newman-Keuls multiple
comparison test were used to compare outcomes in mice of different geno-
types. Data were expressed as mean ± SEM.
ACCESSION NUMBERS
The data for the transcriptome analysis described in this manuscript have
been deposited in NCBI’s Gene Expression Omnibus and are available at
GEO: GSE72546.ll Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc. 509
Cell Metabolism
Islet Microenvironment and b Cell RegenerationSUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.02.001.
ACKNOWLEDGMENTS
We thank Drs. S. Efrat, P. Campochiaro, and M. Gannon for providing mice.
We thank C.V.E. Wright and R. Stein for antibody gifts. We are grateful to
Drs. P. Kendall, J. Thomas, V. Babaev, A. Hatzopoulos, P. Young, and Y.
Dor for helpful discussions. This work was supported by grants from the
Department of Veterans Affairs, the NIH (DK66636, DK69603, DK63439,
DK62641, DK72473, DK089572, DK09538, DK68764), JDRF, and the Vander-
bilt Diabetes Research and Training Center (DK20593). Islet isolation was per-
formed in the Vanderbilt Islet Procurement and Analysis Core (DK20593). Bone
marrow isolation and transplantation were performed in the Vanderbilt Cardio-
vascular Pathophysiology &Complications Core (DK59637). Image acquisition
was performed in part through use of the Vanderbilt Cell Imaging Shared
Resource (CA68485, DK20593, DK58404, HD15052, DK59637, EY08126).
Flow cytometry analysis was performed in the Vanderbilt Flow Cytometry
Shared Resource (P30 CA68485, DK058404).
Received: October 12, 2012
Revised: March 5, 2013
Accepted: January 27, 2014
Published: February 20, 2014
REFERENCES
Agudo, J., Ayuso, E., Jimenez, V., Casellas, A., Mallol, C., Salavert, A., Tafuro,
S., Obach, M., Ruzo, A., Moya, M., et al. (2012). Vascular Endothelial Growth
Factor-Mediated Islet Hypervascularization and Inflammation Contribute to
Progressive Reduction of b-Cell Mass. Diabetes 61, 2851–2861.
Apte, S.S. (2009). A disintegrin-like and metalloprotease (reprolysin-type) with
thrombospondin type 1 motif (ADAMTS) superfamily: functions and mecha-
nisms. J. Biol. Chem. 284, 31493–31497.
Banaei-Bouchareb, L., Gouon-Evans, V., Samara-Boustani, D., Castellotti,
M.C., Czernichow, P., Pollard, J.W., and Polak, M. (2004). Insulin cell mass
is altered in Csf1op/Csf1op macrophage-deficient mice. J. Leukoc. Biol. 76,
359–367.
Bardin, N., Blot-Chabaud, M., Despoix, N., Kebir, A., Harhouri, K., Arsanto,
J.-P., Espinosa, L., Perrin, P., Robert, S., Vely, F., et al. (2009). CD146 and
its soluble form regulate monocyte transendothelial migration. Arterioscler.
Thromb. Vasc. Biol. 29, 746–753.
Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A., and Marme´, D.
(1996). Migration of human monocytes in response to vascular endothelial
growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87,
3336–3343.
Brissova, M., Fowler, M., Wiebe, P., Shostak, A., Shiota, M., Radhika, A., Lin,
P.C., Gannon, M., and Powers, A.C. (2004). Intraislet endothelial cells
contribute to revascularization of transplanted pancreatic islets. Diabetes
53, 1318–1325.
Brissova, M., Shostak, A., Shiota, M., Wiebe, P.O., Poffenberger, G., Kantz, J.,
Chen, Z., Carr, C., Jerome, W.G., Chen, J., et al. (2006). Pancreatic islet
production of vascular endothelial growth factor—a is essential for islet vascu-
larization, revascularization, and function. Diabetes 55, 2974–2985.
Butler, J.M., Kobayashi, H., and Rafii, S. (2010a). Instructive role of the
vascular niche in promoting tumour growth and tissue repair by angiocrine
factors. Nat. Rev. Cancer 10, 138–146.
Butler, J.M., Nolan, D.J., Vertes, E.L., Varnum-Finney, B., Kobayashi, H.,
Hooper, A.T., Seandel, M., Shido, K., White, I.A., Kobayashi, M., et al.
(2010b). Endothelial cells are essential for the self-renewal and repopulation
of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251–264.
Cai, Q., Brissova, M., Reinert, R.B., Pan, F.C., Brahmachary, P., Jeansson, M.,
Shostak, A., Radhika, A., Poffenberger, G., Quaggin, S.E., et al. (2012).510 Cell Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc.Enhanced expression of VEGF-A in b cells increases endothelial cell number
but impairs islet morphogenesis and b cell proliferation. Dev. Biol. 367, 40–54.
Carmeliet, P., and Tessier-Lavigne, M. (2005). Common mechanisms of nerve
and blood vessel wiring. Nature 436, 193–200.
Chen, H., Gu, X., Su, I.-H., Bottino, R., Contreras, J.L., Tarakhovsky, A., and
Kim, S.K. (2009). Polycomb protein Ezh2 regulates pancreatic beta-cell
Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23,
975–985.
Dai, C., Brissova, M., Hang, Y., Thompson, C., Poffenberger, G., Shostak, A.,
Chen, Z., Stein, R., and Powers, A.C. (2012). Islet-enriched gene expression
and glucose-induced insulin secretion in human and mouse islets.
Diabetologia 55, 707–718.
Dhawan, S., Tschen, S.-I., and Bhushan, A. (2009). Bmi-1 regulates the Ink4a/
Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23, 906–911.
Diamond, J.R., and Pesek-Diamond, I. (1991). Sublethal X-irradiation during
acute puromycin nephrosis prevents late renal injury: role of macrophages.
Am. J. Physiol. 260, F779–F786.
Ding, B.-S., Nolan, D.J., Butler, J.M., James, D., Babazadeh, A.O.,
Rosenwaks, Z., Mittal, V., Kobayashi, H., Shido, K., Lyden, D., et al. (2010).
Inductive angiocrine signals from sinusoidal endothelium are required for liver
regeneration. Nature 468, 310–315.
Ding, B.-S., Nolan, D.J., Guo, P., Babazadeh, A.O., Cao, Z., Rosenwaks, Z.,
Crystal, R.G., Simons, M., Sato, T.N., Worgall, S., et al. (2011). Endothelial-
derived angiocrine signals induce and sustain regenerative lung alveolariza-
tion. Cell 147, 539–553.
Efrat, S., Fusco-DeMane, D., Lemberg, H., al Emran, O., and Wang, X. (1995).
Conditional transformation of a pancreatic beta-cell line derived from trans-
genic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad.
Sci. USA 92, 3576–3580.
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Jung, S.,
Chimenti, S., Landsman, L., Abramovitch, R., and Keshet, E. (2006). VEGF-
induced adult neovascularization: recruitment, retention, and role of accessory
cells. Cell 124, 175–189.
Hasegawa, Y., Ogihara, T., Yamada, T., Ishigaki, Y., Imai, J., Uno, K., Gao, J.,
Kaneko, K., Ishihara, H., Sasano, H., et al. (2007). Bone marrow (BM) trans-
plantation promotes beta-cell regeneration after acute injury through BM cell
mobilization. Endocrinology 148, 2006–2015.
He, H., Xu, J., Warren, C.M., Duan, D., Li, X., Wu, L., and Iruela-Arispe, M.L.
(2012). Endothelial cells provide an instructive niche for the differentiation
and functional polarization of M2-like macrophages. Blood 120, 3152–3162.
Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray,
D.A., and Bhatia, M. (2003). Bone marrow-derived stem cells initiate pancre-
atic regeneration. Nat. Biotechnol. 21, 763–770.
King, M., Pearson, T., Shultz, L.D., Leif, J., Bottino, R., Trucco, M., Atkinson,
M.A., Wasserfall, C., Herold, K.C., Woodland, R.T., et al. (2008). A new Hu-
PBL model for the study of human islet alloreactivity based on NOD-scid
mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
Clin. Immunol. 126, 303–314.
Kveiborg, M., Albrechtsen, R., Couchman, J.R., and Wewer, U.M. (2008).
Cellular roles of ADAM12 in health and disease. Int. J. Biochem. Cell Biol.
40, 1685–1702.
Lammert, E., Cleaver, O., and Melton, D. (2001). Induction of pancreatic differ-
entiation by signals from blood vessels. Science 294, 564–567.
Lammert, E., Gu, G., McLaughlin, M., Brown, D., Brekken, R., Murtaugh, L.C.,
Gerber, H.-P., Ferrara, N., and Melton, D.A. (2003). Role of VEGF-A in vascu-
larization of pancreatic islets. Curr. Biol. 13, 1070–1074.
Lu, C., Zhu, F., Cho, Y.-Y., Tang, F., Zykova, T., Ma, W.-Y., Bode, A.M., and
Dong, Z. (2006). Cell apoptosis: requirement of H2AX in DNA ladder formation,
but not for the activation of caspase-3. Mol. Cell 23, 121–132.
Magenheim, J., Ilovich, O., Lazarus, A., Klochendler, A., Ziv, O., Werman, R.,
Hija, A., Cleaver, O., Mishani, E., Keshet, E., and Dor, Y. (2011). Blood vessels
restrain pancreas branching, differentiation and growth. Development 138,
4743–4752.
Cell Metabolism
Islet Microenvironment and b Cell RegenerationNakayama, S., Uchida, T., Choi, J.B., Fujitani, Y., Ogihara, T., Iwashita, N.,
Azuma, K., Mochizuki, H., Hirose, T., Kawamori, R., et al. (2009). Impact of
whole body irradiation and vascular endothelial growth factor-A on increased
beta cell mass after bonemarrow transplantation in amousemodel of diabetes
induced by streptozotocin. Diabetologia 52, 115–124.
Nucera, S., Biziato, D., and De Palma, M. (2011). The interplay between
macrophages and angiogenesis in development, tissue injury and regenera-
tion. Int. J. Dev. Biol. 55, 495–503.
Nyman, L.R., Wells, K.S., Head, W.S., McCaughey, M., Ford, E., Brissova, M.,
Piston, D.W., and Powers, A.C. (2008). Real-time, multidimensional in vivo
imaging used to investigate blood flow in mouse pancreatic islets. J. Clin.
Invest. 118, 3790–3797.
Ohno-Matsui, K., Hirose, A., Yamamoto, S., Saikia, J., Okamoto, N., Gehlbach,
P., Duh, E.J., Hackett, S., Chang, M., Bok, D., et al. (2002). Inducible expres-
sion of vascular endothelial growth factor in adult mice causes severe prolifer-
ative retinopathy and retinal detachment. Am. J. Pathol. 160, 711–719.
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. (1997).
‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 407, 313–319.
Peshavaria, M., Larmie, B.L., Lausier, J., Satish, B., Habibovic, A., Roskens,
V., Larock, K., Everill, B., Leahy, J.L., and Jetton, T.L. (2006). Regulation of
pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancrea-
tectomy mouse. Diabetes 55, 3289–3298.
Porat, S., Weinberg-Corem, N., Tornovsky-Babaey, S., Schyr-Ben-Haroush,
R., Hija, A., Stolovich-Rain, M., Dadon, D., Granot, Z., Ben-Hur, V., White,
P., et al. (2011). Control of pancreatic b cell regeneration by glucose meta-
bolism. Cell Metab. 13, 440–449.
Reinert, R.B., Kantz, J., Misfeldt, A.A., Poffenberger, G., Gannon,M., Brissova,
M., and Powers, A.C. (2012). Tamoxifen-Induced Cre-loxP Recombination Is
Prolonged in Pancreatic Islets of Adult Mice. PLoS ONE 7, e33529.
Reinert, R.B., Brissova, M., Shostak, A., Pan, F.C., Poffenberger, G., Cai, Q.,
Hundemer, G.L., Kantz, J., Thompson, C.S., Dai, C., et al. (2013). Vascular
endothelial growth factor-a and islet vascularization are necessary in devel-
oping, but not adult, pancreatic islets. Diabetes 62, 4154–4164.
Reinert, R.B., Cai, Q., Hong, J.-Y., Plank, J.L., Aamodt, K., Prasad, N.,
Aramandla, R., Dai, C., Levy, S., Pozzi, A., et al. (2014). Vascular endothelial
growth factor coordinates islet innervation via vascular scaffolding.
Development, in press. Published online March 18, 2014. http://dx.doi.org/
10.1242/dev.098657.CeRicardo, S.D.S., van Goor, H.H., and Eddy, A.A.A. (2008). Macrophage diver-
sity in renal injury and repair. J. Clin. Invest. 118, 3522–3530.
Rieck, S., and Kaestner, K.H. (2010). Expansion of beta-cell mass in response
to pregnancy. Trends Endocrinol. Metab. 21, 151–158.
Sand, F.W., Ho¨rnblad, A., Johansson, J.K., Lore´n, C., Edsbagge, J., Sta˚hlberg,
A., Magenheim, J., Ilovich, O.,Mishani, E., Dor, Y., et al. (2011). Growth-limiting
role of endothelial cells in endoderm development. Dev. Biol. 352, 267–277.
Sharpe, E.E., 3rd, Teleron, A.A., Li, B., Price, J., Sands, M.S., Alford, K., and
Young, P.P. (2006). The origin and in vivo significance of murine and human
culture-expanded endothelial progenitor cells. Am. J. Pathol. 168, 1710–1721.
Sica, A., and Mantovani, A. (2012). Macrophage plasticity and polarization:
in vivo veritas. J. Clin. Invest. 122, 787–795.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Genet. 21, 70–71.
Tsunawaki, S., Sporn, M., Ding, A., and Nathan, C. (1988). Deactivation of
macrophages by transforming growth factor-beta. Nature 334, 260–262.
Urba´n, V.S., Kiss, J., Kova´cs, J., Go´cza, E., Vas, V., Monostori, E., and Uher, F.
(2008). Mesenchymal stem cells cooperate with bone marrow cells in therapy
of diabetes. Stem Cells 26, 244–253.
Vasir, B., Jonas, J.C., Steil, G.M., Hollister-Lock, J., Hasenkamp, W., Sharma,
A., Bonner-Weir, S., and Weir, G.C. (2001). Gene expression of VEGF and its
receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets.
Transplantation 71, 924–935.
Wang, Y.V., Leblanc, M., Fox, N., Mao, J.-H., Tinkum, K.L., Krummel, K.,
Engle, D., Piwnica-Worms, D., Piwnica-Worms, H., Balmain, A., et al. (2011).
Fine-tuning p53 activity through C-terminal modification significantly contrib-
utes to HSC homeostasis and mouse radiosensitivity. Genes Dev. 25, 1426–
1438.
Ward, T.H., Cummings, J., Dean, E., Greystoke, A., Hou, J.M., Backen, A.,
Ranson, M., and Dive, C. (2008). Biomarkers of apoptosis. Br. J. Cancer 99,
841–846.
Yoshitomi, H., and Zaret, K.S. (2004). Endothelial cell interactions initiate
dorsal pancreas development by selectively inducing the transcription factor
Ptf1a. Development 131, 807–817.
Zhang, H., Fujitani, Y., Wright, C.V.E., and Gannon, M. (2005). Efficient recom-
bination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
Genesis 42, 210–217.ll Metabolism 19, 498–511, March 4, 2014 ª2014 Elsevier Inc. 511
